Format

Send to

Choose Destination
J Clin Endocrinol Metab. 2010 Mar;95(3):1054-9. doi: 10.1210/jc.2009-1378. Epub 2010 Jan 15.

Insulin-like growth factor-I and cancer mortality in older men.

Author information

1
Department of Family and Preventive Medicine, University of California San Diego, 9500 Gilman Drive, La Jolla, California 92093-0631C, USA.

Abstract

CONTEXT:

Although numerous studies have explored the relation of IGF-I with cancer incidence, few have investigated the association between IGF-I and cancer mortality.

OBJECTIVE:

This study examined the association of serum IGF-I levels with cancer mortality in older community-dwelling men.

DESIGN, SETTING, AND PARTICIPANTS:

We conducted a prospective, population-based study of 633 men aged 50 yr and older (mean = 73) who attended a 1988-1991 research clinic visit when blood was obtained for measurement of IGF-I. Participants were followed for vital status through July 2006.

MAIN OUTCOME MEASURE:

All-cancer mortality was assessed.

RESULTS:

Median IGF-I was 96 ng/ml. During the 18-yr follow-up, 368 deaths occurred; 74 (20%) were due to cancer. Cox regression analyses showed a significant quadratic association between IGF-I and all-cancer mortality (P = 0.039). Higher levels of IGF-I were associated with progressively higher risk of cancer death after adjusting for age, IGF-binding protein-1, adiposity, exercise, current smoking, and previous cancer. The adjusted risk of cancer death was statistically significant for IGF-I levels above 120 ng/ml, with magnitudes of effect ranging from 1.61 [95% confidence interval (CI) = 1.28-2.02] to 2.61 (95% CI = 1.46-4.64). For the 46% of men with IGF-I above 100 ng/ml, the risk of fatal cancer was 1.82 (95% CI = 1.11-2.96) compared to the risk with lower levels.

CONCLUSIONS:

Higher serum IGF-I in older men is associated with increased risk of cancer death, independent of age, adiposity, lifestyle, and cancer history. These results suggest caution in the use of IGF-I-enhancing therapies to slow the adverse effects of aging.

PMID:
20080855
PMCID:
PMC2841529
DOI:
10.1210/jc.2009-1378
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center